Literature DB >> 683787

Initial urinary catecholamine metabolite concentrations and prognosis in neuroblastoma.

W E Laug, S E Siegel, K N Shaw, B Landing, J Baptista, M Gutenstein.   

Abstract

Initial urinary catecholamine metabolite and amino acid excretion patterns were examined in 54 children with neuroblastoma. The relationships between prognosis and age at diagnosis, stage of disease, primary site, and histologic grade of tumor were similar in this population to those found in previous studies, but only age and stage were found to be independent prognostic variables. Prognosis in disseminated disease was found to correlate directly with the urinary vanilmandelic acid (VMA)/homovanillic acid (HVA) ratio but not with the absolute levels of HVA. The presence of the dopa metabolite, vanillactic acid, as well as increased amounts of cystathionine and/or low levels of VMA indicated poor prognosis. These results are consistent with the hypothesis that biochemically primitive neuroblastomas deficient in dopamine beta-hydroxylase are move virulent than their mature analogues which produce epinephrine, norepinephrine, and their metabolites.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 683787

Source DB:  PubMed          Journal:  Pediatrics        ISSN: 0031-4005            Impact factor:   7.124


  21 in total

1.  Urine catecholamine levels as diagnostic markers for neuroblastoma in a defined population: implications for ophthalmic practice.

Authors:  S J Smith; N N Diehl; B D Smith; B G Mohney
Journal:  Eye (Lond)       Date:  2010-09-24       Impact factor: 3.775

2.  Intratumorous distribution of catecholaminergic clone cells of human neuroblastoma. A catecholamine fluorescence study.

Authors:  A Nakagawara; T Toyohara; K Ikeda; O Nada; M Tsuneyoshi
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1986

3.  Comparative values of catecholamines and metabolites for the diagnosis of neuroblastoma.

Authors:  Maud Monsaingeon; Yves Perel; Guy Simonnet; Jean-Benoît Corcuff
Journal:  Eur J Pediatr       Date:  2003-03-27       Impact factor: 3.183

4.  Neuroblastoma: an analysis of 160 cases.

Authors:  J L Grosfeld; R L Baehner
Journal:  World J Surg       Date:  1980-01       Impact factor: 3.352

Review 5.  Biology of pediatric peripheral neuroectodermal tumors.

Authors:  C J Thiele
Journal:  Cancer Metastasis Rev       Date:  1991-12       Impact factor: 9.264

6.  A combined evaluation of biochemical and morphological changes during human neuroblastoma cell differentiation.

Authors:  M Lanciotti; P G Montaldo; S Folghera; E Lucarelli; P Cornaglia-Ferraris; M Ponzoni
Journal:  Cell Mol Neurobiol       Date:  1992-06       Impact factor: 5.046

7.  The value of determination of homovanillic and vanillylmandelic acids in plasma for the diagnosis and follow-up of neuroblastoma in children.

Authors:  M Gahr; D H Hunneman
Journal:  Eur J Pediatr       Date:  1987-09       Impact factor: 3.183

Review 8.  Imaging of Horner syndrome in pediatrics: association with neuroblastoma.

Authors:  Hedieh Khalatbari; Gisele E Ishak
Journal:  Pediatr Radiol       Date:  2020-10-06

9.  Expression and function of TRK-B and BDNF in human neuroblastomas.

Authors:  A Nakagawara; C G Azar; N J Scavarda; G M Brodeur
Journal:  Mol Cell Biol       Date:  1994-01       Impact factor: 4.272

10.  Congenital heart disease and neuroblastoma: just coincidence?

Authors:  R Holzer; R C G Franklin
Journal:  Arch Dis Child       Date:  2002-07       Impact factor: 3.791

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.